Katie Rielly-Gauvin
Ms. Rielly-Gauvin served as Vice President of Global Commercial Development at AbbVie and brings over 30 years of diverse pharmaceutical industry experience to Liquidia’s Board. At AbbVie, she was responsible for developing the strategic commercial direction of key compounds in the company’s pipeline across core therapeutic areas in Immunology, Oncology, Neuroscience and Specialty. Previously, Ms. Rielly-Gauvin worked in the Johnson & Johnson family of companies in commercial, medical affairs and research capacities, including Vice President and General Manager for the Janssen Commercial CNS organization. She holds a B.S. in Chemistry from Simmons University and an MBA in Economics from Rutgers University.